10/24/2011

Data from two midstage clinical trials show that Halozyme Therapeutics' insulin PH20 was as effective as Eli Lilly and Co.'s Humalog in controlling blood glucose levels in patients with type 1 and type 2 diabetes. Halozyme is seeking partnerships and opportunities worldwide to make its insulin available.

Related Summaries